{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:18:19Z","timestamp":1791724699845,"version":"4.3.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NIH","award":["R35GM134934"],"award-info":[{"award-number":["R35GM134934"]}]},{"name":"NIH","award":["F30OD030022"],"award-info":[{"award-number":["F30OD030022"]}]},{"name":"CDC","award":["U01CK000587"],"award-info":[{"award-number":["U01CK000587"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,4]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n MRSA is one of the most common causes of hospital- and community-acquired infections. MRSA is resistant to many antibiotics, including \u03b2-lactam antibiotics, fluoroquinolones, lincosamides, macrolides, aminoglycosides, tetracyclines and chloramphenicol.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To identify patient-level characteristics that may be associated with phenotype variations and that may help improve prescribing practice and antimicrobial stewardship.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Chain graphs for resistance phenotypes were learned from invasive MRSA surveillance data collected by the CDC as part of the Emerging Infections Program to identify patient level risk factors for individual resistance outcomes reported as MIC while accounting for the correlations among the resistance traits. These chain graphs are multilevel probabilistic graphical models (PGMs) that can be used to quantify and visualize the complex associations among multiple resistance outcomes and their explanatory variables.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Some phenotypic resistances had low connectivity to other outcomes or predictors (e.g. tetracycline, vancomycin, doxycycline and rifampicin). Only levofloxacin susceptibility was associated with healthcare-associated infections. Blood culture was the most common predictor of MIC. Patients with positive blood culture had significantly increased MIC of chloramphenicol, erythromycin, gentamicin, lincomycin and mupirocin, and decreased daptomycin and rifampicin MICs. Some regional variations were also observed.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The differences in resistance phenotypes between patients with previous healthcare use or positive blood cultures, or from different states, may be useful to inform first-choice antibiotics to treat clinical MRSA cases. Additionally, we demonstrated multilevel PGMs are useful to quantify and visualize interactions among multiple resistance outcomes and their explanatory variables.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/jacamr\/dlac068","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T23:06:43Z","timestamp":1656976003000},"source":"Crossref","is-referenced-by-count":3,"title":["Identifying patient-level risk factors associated with non-\u03b2-lactam resistance outcomes in invasive MRSA infections in the United States using chain graphs"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-1816","authenticated-orcid":false,"given":"William J","family":"Love","sequence":"first","affiliation":[{"name":"Department of Population Health and Pathobiology, North Carolina State University , Raleigh, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Annie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Population Health and Pathobiology, North Carolina State University , Raleigh, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lanzas","sequence":"additional","affiliation":[{"name":"Department of Population Health and Pathobiology, North Carolina State University , Raleigh, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"2022072609414826600_dlac068-B1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.coph.2011.07.007","article-title":"Co-resistance: an opportunity for the bacteria and resistance genes","volume":"11","author":"Canton","year":"2011","journal-title":"Curr Opin in Pharm"},{"key":"2022072609414826600_dlac068-B2","article-title":"Antimicrobial Resistance: Global Report on Surveillance","author":"WHO","year":"2014"},{"key":"2022072609414826600_dlac068-B3","article-title":"Antibiotic Resistance Threats in the United States","author":"CDC","year":"2019"},{"key":"2022072609414826600_dlac068-B4","doi-asserted-by":"crossref","first-page":"7.2.18","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic resistance and the MRSA problem","volume":"7","author":"Vestegard","year":"2019","journal-title":"Microb Spectrum"},{"key":"2022072609414826600_dlac068-B5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Nikaido","year":"2009","journal-title":"Ann Rev Biochem"},{"key":"2022072609414826600_dlac068-B6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"2022072609414826600_dlac068-B7","doi-asserted-by":"crossref","first-page":"e1007763","DOI":"10.1371\/journal.ppat.1007763","article-title":"On the evolutionary ecology of multidrug resistance in bacteria","volume":"15","author":"Lehtinen","year":"2019","journal-title":"PLoS Pathogens"},{"issue":"Suppl 1","key":"2022072609414826600_dlac068-B8","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/jac\/dkn241","article-title":"The growing burden of antimicrobial resistance","volume":"62","author":"Hawkey","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2022072609414826600_dlac068-B9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhin.2009.05.002","article-title":"Screening and isolation for infection control","volume":"73","author":"Tacconelli","year":"2009","journal-title":"J Hosp Infect"},{"key":"2022072609414826600_dlac068-B10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.artmed.2003.11.003","article-title":"Understanding tuberculosis epidemiology using structured statistical models","volume":"30","author":"Getoor","year":"2004","journal-title":"Artif Intell Med"},{"key":"2022072609414826600_dlac068-B11","volume-title":"Probabilistic Graphical Models","author":"Koller","year":"2009"},{"key":"2022072609414826600_dlac068-B12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2288-8-70","article-title":"Reducing bias through directed acyclic graphs","volume":"8","author":"Shrier","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"2022072609414826600_dlac068-B13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jac\/dkaa408","article-title":"Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling","volume":"76","author":"Cherny","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2022072609414826600_dlac068-B14","doi-asserted-by":"crossref","first-page":"e1005160","DOI":"10.1371\/journal.pcbi.1005160","article-title":"Markov networks of collateral resistance: national antimicrobial resistance monitoring system surveillance results from Escherichia coli isolates, 2004-2012","volume":"12","author":"Love","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"2022072609414826600_dlac068-B15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1017\/S0950268818000833","article-title":"Phenotypical resistance correlation networks for 10 non-typhoidal Salmonella subpopulations in an active antimicrobial surveillance programme","volume":"146","author":"Love","year":"2018","journal-title":"Epidemiol Infect"},{"key":"2022072609414826600_dlac068-B16","article-title":"Invasive Staphylococcus aureus Infection Tracking","author":"CDC Emerging Infections Program"},{"key":"2022072609414826600_dlac068-B17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/AAC.38.2.184","article-title":"Use of multivariate analysis to compare antimicrobial agents on the basis of in vitro activity data","volume":"38","author":"Hernandez","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072609414826600_dlac068-B18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1994","journal-title":"J R Statist Soc B"},{"key":"2022072609414826600_dlac068-B19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/biostatistics\/kxm045","article-title":"Sparse inverse covariance estimation with the graphical lasso","volume":"9","author":"Friedman","year":"2008","journal-title":"Biostatistics"},{"key":"2022072609414826600_dlac068-B20","first-page":"1","article-title":"Penalized maximum likelihood estimation of multi-layered Gaussian graphical models","volume":"17","author":"Lin","year":"2016","journal-title":"J Mach Learn Res"},{"key":"2022072609414826600_dlac068-B21","first-page":"2869","article-title":"Confidence intervals and hypothesis testing for high-dimensional regression","volume":"15","author":"Javanmard","year":"2014","journal-title":"J Mach Learn Res"},{"key":"2022072609414826600_dlac068-B22","first-page":"1432","article-title":"Stability approach to regularization selection (StARS) for high dimensional graphical models","volume":"24","author":"Liu","year":"2010","journal-title":"Adv Neural Inf Process Sys"},{"key":"2022072609414826600_dlac068-B23","volume-title":"R: A Language and Environment for Statistical Computing","author":"Core Team","year":"2022"},{"key":"2022072609414826600_dlac068-B24","article-title":"MultiLayerGGM. GitHub","author":"Lin"},{"key":"2022072609414826600_dlac068-B25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022072609414826600_dlac068-B26","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","article-title":"An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"42","author":"Patel","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2022072609414826600_dlac068-B27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ja.2014.107","article-title":"Resistance to rifampicin: a review","volume":"67","author":"Goldstein","year":"2014","journal-title":"J Antibiot"},{"key":"2022072609414826600_dlac068-B28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12948","article-title":"Mechanisms of drug resistance: daptomycin resistance","author":"Tran","year":"2015","journal-title":"Ann NY Acad Sci"},{"key":"2022072609414826600_dlac068-B29","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/AAC.05325-11","article-title":"MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus","volume":"56","author":"Seah","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072609414826600_dlac068-B30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/605495","article-title":"Mupirocin resistance","volume":"49","author":"Patel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2022072609414826600_dlac068-B31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1017\/S0950268800029939","article-title":"Transmissible mupirocin resistance in Staphylococcus aureus","volume":"102","author":"Rahman","year":"1989","journal-title":"Epidemiol Infect"},{"key":"2022072609414826600_dlac068-B32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1128\/AAC.39.6.1272","article-title":"Characterization of a conjugative staphylococcal mupirocin resistance plasmid","volume":"39","author":"Morton","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072609414826600_dlac068-B33","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jac\/dkh457","article-title":"Nucleotide sequence and organization of the multiresistance plasmid pSCFS1 from Staphylococcus sciuri","volume":"54","author":"Kehrenberg","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2022072609414826600_dlac068-B34","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1093\/jac\/dks245","article-title":"Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time","volume":"67","author":"Knight","year":"2012","journal-title":"J Antimicrob Chemotherapy"},{"key":"2022072609414826600_dlac068-B35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/163.6.1279","article-title":"Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus","volume":"163","author":"Blumberg","year":"1991","journal-title":"J Infect Dis"},{"key":"2022072609414826600_dlac068-B36","doi-asserted-by":"crossref","first-page":"e00020-18","DOI":"10.1128\/CMR.00020-18","article-title":"Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology","volume":"31","author":"Lakhundi","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"2022072609414826600_dlac068-B37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/ciz158","article-title":"Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005-2013","volume":"71","author":"See","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022072609414826600_dlac068-B38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijantimicag.2018.04.003","article-title":"The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: a county-level, US-wide analysis","volume":"52","author":"Andreatos","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2022072609414826600_dlac068-B39","first-page":"e000058","article-title":"Pan-genomic perspective on the evolution of the Staphylococcus aureus USA300 epidemic","volume":"2","author":"Jamrozy","year":"2016","journal-title":"Microb Genom"},{"key":"2022072609414826600_dlac068-B40","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"2022072609414826600_dlac068-B41","first-page":"1970","article-title":"National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011","volume":"173","author":"Dantes","year":"2013","journal-title":"JAMA Int Med"},{"key":"2022072609414826600_dlac068-B42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12917-019-1965-y","article-title":"Additive Bayesian networks for antimicrobial resistance and potential risk factors in non-typhoidal Salmonella isolates from layer hens in Uganda","volume":"15","author":"Hartnack","year":"2019","journal-title":"BMC Vet Res"},{"key":"2022072609414826600_dlac068-B43","volume-title":"Performance Standards for Antimicrobial Disk Susceptibility Tests\u2014Twenty-Ninth Edition: M100","author":"CLSI","year":"2019"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/4\/4\/dlac068\/45066767\/dlac068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/4\/4\/dlac068\/45066767\/dlac068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T09:00:35Z","timestamp":1727514035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlac068\/6628831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlac068","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.12.21266278","asserted-by":"object"}]},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,7,4]]},"article-number":"dlac068"}}